Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
SARS-CoV-2 infection stimulates a complex activation of the immune system. Eosinophils belong to the host’s defense equipment against respiratory viruses. In the first phase of the infection, eosinophils contribution is probably appropriate and beneficial, as they facilitate the suppression of the v...
Main Authors: | Daniele Pala, Marco Pistis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.622554/full |
Similar Items
-
Severe Eosinophilic Asthma
by: Agamemnon Bakakos, et al.
Published: (2019-09-01) -
Treatment Challenges in Severe Eosinophilic Asthma: Differential Response to Anti-IL-5 and Anti-IL-5R Therapy
by: Agamemnon Bakakos, et al.
Published: (2021-04-01) -
Eosinophils and childhood asthma
by: Bong Seok Choi
Published: (2021-02-01) -
The enigmatic eosinophil: investigation of the biological role of eosinophils in parasitic helmint infection
by: Karen S Ovington, et al.
Published: (1997-12-01) -
MONOCLONAL ANTIBODY-BASED THERAPY FOR EOSINOPHILIC OESOPHAGITIS
by: Garry Walsh
Published: (2016-12-01)